Celerion is committed to swift, exceptional clinical research through translational medicine. Every day, we use our experience, agility, and innovative research strategies to help get drugs to market faster. Celerion offers one of the most experienced clinical pharmacology research networks in the industry.
Celerion is increasing our team of Research Nurses and invite applications to join the clinical conduct team at our Phase I clinical trial facility in Belfast, N. Ireland.
We are looking for a registered nurse who would like to learn new skills in a clinical research setting working on both patient and healthy adult clinical trials within a multi-disciplinary team. Full-time (37.5hr/week) positions are available.
The responsibilities include administering medication (including IV) or new drug delivery devices to study participants, collecting safety data such as vital signs, ECGs, cardiac monitoring, phlebotomy and safety monitoring of adverse events. Additional skills in respiratory medicine, particularly CF, COPD and asthma, would be desirable but training will be provided on all equipment used.
Full training on clinical research nursing skills and Good Clinical Practice will be provided. Celerion will also provide training on phlebotomy, IV cannulation, IV dosing, ECGs and use of respiratory equipment where necessary. ILS training is provided annually and paid for by Celerion. NMC registration renewal fees are also eligible for reimbursement.
An attractive salary and benefits package is provided including pension, life assurance, income protection insurance and private medical insurance.
Celerion is an equal opportunities employer.

Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines.
With over 50 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiovascular safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings.
Our operations are strategically located in:
Lincoln, Nebraska (Corporate Headquarters)
Philadelphia, Pennsylvania
Phoenix, Arizona
Belfast, Northern Ireland,UK
Zurich, Switzerland
Vienna, Austria
Richmond, Virginia
Montreal, Quebec, Canada
For more information, visit: www.celerion.com